ERSTE STOCK BIOTEC CZK R01 (VTA)/ AT0000A0XYP0 /
| NAV20/09/2024 | Chg.+187.1201 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 13,899.3301CZK | +1.36% | Full reinvestment | Equity Sector Biotechnology | Erste AM ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013 | 6.06 | 4.16 | 10.68 | 6.33 | 6.48 | -3.18 | 9.10 | -0.85 | 5.31 | -3.70 | 14.90 | -0.11 | +68.77% |
| 2014 | 12.51 | 7.09 | -15.75 | -0.83 | 6.52 | 6.14 | 2.72 | 10.21 | 3.08 | 8.36 | 2.83 | 4.26 | +54.28% |
| 2015 | 13.35 | 6.10 | 6.20 | -5.52 | 8.29 | -3.77 | 6.63 | -8.60 | -17.49 | 15.60 | 7.12 | -3.47 | +20.88% |
| 2016 | -26.81 | -0.46 | -5.58 | 9.99 | 2.48 | -7.17 | 12.53 | -2.01 | 3.27 | -6.46 | 11.85 | -5.24 | -18.75% |
| 2017 | 0.76 | 10.07 | -1.92 | 0.03 | -9.50 | 6.57 | 0.61 | -0.21 | 3.38 | -5.11 | -3.78 | 4.84 | +4.26% |
| 2018 | 1.06 | -2.65 | -3.71 | 1.49 | 9.13 | 2.51 | 1.78 | 8.83 | -1.35 | -13.87 | 3.63 | -12.89 | -8.63% |
| 2019 | 17.96 | 8.95 | -4.32 | -1.15 | -3.39 | 2.85 | 2.67 | -4.75 | -5.49 | 4.67 | 12.57 | 0.51 | +32.21% |
| 2020 | -4.95 | -3.10 | 1.79 | 13.10 | 3.35 | -0.76 | -6.21 | -5.86 | 5.55 | 1.10 | -3.74 | 2.42 | +1.02% |
| 2021 | 2.95 | -2.57 | -3.18 | -1.71 | -5.90 | 8.49 | -2.10 | 4.33 | -3.20 | -0.62 | -2.47 | -1.83 | -8.33% |
| 2022 | -12.69 | -0.85 | 3.92 | -0.32 | -4.16 | 3.20 | 5.87 | 0.71 | 2.08 | 5.49 | -2.64 | -3.90 | -4.73% |
| 2023 | -1.17 | -3.04 | -2.68 | 1.25 | 1.37 | -1.55 | 1.30 | 1.65 | -0.01 | -6.19 | -0.99 | 15.10 | +3.72% |
| 2024 | 1.73 | 6.29 | -2.90 | -6.30 | -1.42 | 9.89 | 6.49 | -2.53 | -1.13 | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 16.48% | 15.67% | 17.82% | 21.20% | 24.08% |
| Sharpe ratio | 0.60 | 0.61 | 0.72 | -0.18 | -0.05 |
| Best month | +15.10% | +9.89% | +15.10% | +15.10% | +15.10% |
| Worst month | -6.30% | -6.30% | -6.30% | -12.69% | -12.69% |
| Maximum loss | -11.78% | -8.17% | -11.78% | -26.80% | -35.30% |
| Outperformance | -1.94% | - | -7.59% | -30.56% | -29.75% |
All quotes in CZK
Share classes
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| ERSTE Stock Biotec D02 VTIA | Full reinvestment | 3,176.6599 | +16.27% | -0.72% | |
| ERSTE Stock Biotec D02 VTIA | Full reinvestment | 52,108.5313 | +17.00% | +14.60% | |
| ERSTE Stock Biotec D02 VTIA | Full reinvestment | 129.3200 | +13.89% | +0.94% | |
| ERSTE Stock Biotec D01 A | paying dividend | 126.1000 | +13.17% | +0.29% | |
| ERSTE Stock Biotec D01 T | reinvestment | 125.1100 | +13.17% | +0.29% | |
| ERSTE STOCK BIOTEC EUR R01 (VTA) | Full reinvestment | 553.8700 | +13.16% | +0.28% | |
| ERSTE STOCK BIOTEC HUF R01 (VTA) | Full reinvestment | 218,183.5625 | +16.20% | +11.93% | |
| ERSTE STOCK BIOTEC CZK R01 (VTA) | Full reinvestment | 13,899.3301 | +16.21% | -0.82% | |
| ERSTE STOCK BIOTEC EUR R01 (A) | paying dividend | 504.5500 | +13.17% | +0.29% | |
| ERSTE STOCK BIOTEC EUR R01 (T) | reinvestment | 504.5200 | +13.17% | +0.29% |
Performance
| YTD | +9.35% | ||
|---|---|---|---|
| 6 Months | +6.36% | ||
| 1 Year | +16.21% | ||
| 3 Years | -0.82% | ||
| 5 Years | +12.29% | ||
| 10 Years | +46.07% | ||
| Since start | +210.46% | ||
| Year | |||
| 2023 | +3.72% | ||
| 2022 | -4.73% | ||
| 2021 | -8.33% | ||
| 2020 | +1.02% | ||
| 2019 | +32.21% | ||
| 2018 | -8.63% | ||
| 2017 | +4.26% | ||
| 2016 | -18.75% | ||
| 2015 | +20.88% | ||
